Eversense 365’s Rollout Extends the Chronic-Care Pull-Through Model
Ascensia’s rollout of Eversense 365 highlights how chronic-care devices are evolving into recurring monitoring platforms with stronger pull-through economics.
What is this trend?
Eversense 365’s rollout shows chronic-care devices are shifting from one-time hardware sales to longer-duration monitoring relationships that pull through software, reimbursement, and channel revenue.
- CGM is moving from sensor placement to year-long monitoring service models.
- Reimbursement and channel access now matter as much as device performance.
- Software integration is becoming the main lock-in for chronic-care platforms.
- Longer-duration devices create recurring revenue beyond the initial procedure.
- The winners will own the monitoring layer, not just the implant or sensor.
What’s the latest?
Ascensia began the first rollout of Senseonics’ FDA-cleared Eversense 365 on October 10, extending CGM from a short-cycle sensor sale into a one-year monitoring relationship.
How it developed
- Orchestration, compliance, and utilization are reshaping medtech value, while interoperable stacks gain ground
- Procedure-Led Demand Is Repricing Device Markets
- Subscription Care Stacks, Drone-Enabled Last-Mile Monitoring, and Interoperability as the New AID Moat
- Aging and Chronic Care Demand
Go deeper
Curated long-form picks on this trend — podcasts, videos, and analysis, by vantage.
If you sell into this industry
Prostate Biopsy Needles Market To 2035: Transperineal Shift and Aging Demographics Fuel Growth - News and Statistics - IndexBox
News trends report with market stats on prostate biopsy needles, covering transperineal shift and aging demand.
IndexBox · News
Read →
AI-Driven Insights Revolutionize Cardiovascular Care and Adoption
Opinion podcast interview with Jim Hartman on AI coronary CTA pre-screening that reprices procedure-led demand.
The AI in Business Podcast · Podcast
Listen from 23:29 →
Risks And Trade-Offs In Medical Device Pricing Transparency
Opinion piece on Medicare implant pricing, transparency effects, and device repricing under procedure-led demand.
Thoughts on Healthcare Markets & Technology · Substack
Read →If you invest in this industry
Surgical Devices Market Size to Worth USD 27.14 Billion by 2030, at a CAGR of 14.7% – MarketsandMarkets™
Research data on surgical devices market growth, showing procedure-led demand repricing device markets.
Yahoo! Finance Canada · News
Read →Endoscopes Market Size to Reach USD 41.09 Billion by 2035 as Disposable and AI-Assisted Systems Gain Ground – SNS Insider
News trends market analysis projecting endoscopes growth to 2035, driven by disposable and AI-assisted systems.
Business Upturn · News
Read →
MedTech Investment Insights: Market Size, Fast‑Follower Strategy, and Clinical Trial Bottlenecks
Podcast analysis with VC investors on fast-follower MedTech entry, repricing markets via approvals and trial costs.
State of Medtech · Podcast
Listen from 37:51 →